Comparison of CHA2DS2-VASc and C2HEST scores for predicting the incidence of atrial fibrillation among patients with end-stage renal disease. (November 2020)

• Record Type: Journal Article
• Authors: Hu, Wei-Syun; Lin, Cheng-Li
• Is Part Of: Perfusion. Volume 35:Number 8(2020)
• Page Start: 842
• Page End: 846
• Publication Date: 2020-11
• Subjects: atrial fibrillation -- end stage renal disease -- risk; Perfusion (Physiology) -- Periodicals; Blood -- Circulation, Artificial -- Periodicals; Heart -- Surgery -- Periodicals; Extracorporeal Circulation -- Periodicals; Perfusion -- Periodicals; Circulation extracorporelle -- Périodiques; Perfusion -- Périodiques; 617.41
• DOI: 10.1177/0267659120930931
• Languages: English
• ISSNs: 0267-6591

Abstract

Purpose: The authors have studied assessment of CHA2DS2-VASc score versus C2HEST score in atrial fibrillation risk prediction in end-stage renal disease patients. Methods: The authors conducted this study by Longitudinal Health Insurance Database 2000. The authors totally enrolled 4, 601 end-stage renal disease patients. The predictive capability of atrial fibrillation by using CHA2DS2-VASc and C2HEST score was estimated by area under the receiver operating characteristic curve (AUROC). Results: The AUROC for CHA2DS2-VASc score in predicting atrial fibrillation events was 0.5786, and AUROC for C2HEST score for atrial fibrillation prediction was 0.5983. Conclusion: Both scores yield almost identical AUROC values implying no difference in predictive power. Further work is warranted to verify the prognostic value of the current scores.